We are live on ! Find out more
IMVTW

Immunovant, Inc. Warrants expiring 12/18/2024
IMVTW

Delisted

IMVTW was delisted on the 15th of June, 2020.

Back to rankings

18 hedge funds and large institutions have $19.9M invested in Immunovant, Inc. Warrants expiring 12/18/2024 in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.07M
2
GL
Governors Lane
New York
+$1.68M
3
BFM
Boothbay Fund Management
New York
+$1.44M
4
DKCM
Davidson Kempner Capital Management
New York
+$1.06M
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$840K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$11.3M +$1.44M +710,559 New
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$2.04M +$2.07M +1,020,000 New
GL
3
Governors Lane
New York
$1.66M +$1.68M +828,004 New
DKCM
4
Davidson Kempner Capital Management
New York
$996K +$1.06M +524,400 New
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$809K +$840K +414,952 New
6CM
6
683 Capital Management
New York
$557K +$563K +278,258 New
CAC
7
Cowen and Company
New York
$490K +$497K +245,198 New
WAM
8
Weiss Asset Management
Massachusetts
$399K +$404K +199,600 New
KPF
9
K2 Principal Fund
Ontario, Canada
$332K +$337K +166,200 New
WAM
10
Wolverine Asset Management
Illinois
$201K +$204K +100,950 New
MP
11
Mangrove Partners
Connecticut
$200K +$203K +100,000 New
RCM
12
Rivernorth Capital Management
Florida
$200K +$203K +100,000 New
VOAM
13
Vertex One Asset Management
British Columbia, Canada
$200K +$203K +100,000 New
BCM
14
Basso Capital Management
Connecticut
$189K +$191K +94,389 New
AGM
15
Alpine Global Management
New York
$150K +$152K +75,000 New
Walleye Trading
16
Walleye Trading
New York
$125K +$127K +62,542 New
PC
17
Periscope Capital
Ontario, Canada
$70K +$71.2K +35,154 New
UBS Group
18
UBS Group
Switzerland
$30K +$30.4K +15,000 New

IMVTW Hedge Fund Activity: Q4 2019 in Review

18 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) for Q4 2019, worth a combined $19.9M.

Buyers outnumbered sellers: 18 funds opened new IMVTW positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $2.07M.

  • 18 institutional investors held Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $19.9M of Immunovant, Inc. Warrants expiring 12/18/2024 stock for Q4 2019.
  • 18 funds opened new Immunovant, Inc. Warrants expiring 12/18/2024 positions in Q4 2019 and 0 closed out, a net change of +18 holders.
  • The largest Immunovant, Inc. Warrants expiring 12/18/2024 buyer in Q4 2019 was Adage Capital Partners, an estimated $2.07M added.

Based on aggregated 13F filings for Q4 2019.